Literature DB >> 9767593

Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets.

D S Black1, L G Montagna, S Zitsmann, J B Bliska.   

Abstract

YopH is a protein tyrosine phosphatase (PTP) that is delivered into host mammalian cells via a type III secretion pathway in pathogenic Yersinia species. Although YopH is a highly active PTP, it preferentially targets a subset of tyrosine-phosphorylated proteins in host cells, including p130Cas. Previous in vitro studies have indicated that the carboxy-terminal PTP domain contributes specificity to the interaction of YopH with substrates. However, it is not known if the PTP domain is sufficient for substrate recognition by YopH. Here, we have identified paxillin as an additional substrate of YopH in HeLa cells. In addition, we have identified a domain in the amino-terminal region of YopH that binds to both p130Cas and paxillin and is required for the efficient recognition of substrates by the wild-type enzyme. This 'substrate-binding' domain exhibits a ligand specificity that is similar to that of the Crk Src homology 2 (SH2) domain, and it binds substrates directly in a phosphotyrosine-dependent manner. The substrate-binding domain of YopH may represent a novel type of protein-protein interaction module, as it lacks significant sequence similarity with any known SH2 or phosphotyrosine-binding (PTB) domain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767593     DOI: 10.1046/j.1365-2958.1998.01014.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  26 in total

Review 1.  Molecular and cell biology aspects of plague.

Authors:  G R Cornelis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  NMR-based design and evaluation of novel bidentate inhibitors of the protein tyrosine phosphatase YopH.

Authors:  Marilisa Leone; Elisa Barile; Jesus Vazquez; Angel Mei; Donald Guiney; Russel Dahl; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2010-04-28       Impact factor: 2.817

3.  Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis.

Authors:  Nadine Grosdent; Isabelle Maridonneau-Parini; Marie-Paule Sory; Guy R Cornelis
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 4.  Process of protein transport by the type III secretion system.

Authors:  Partho Ghosh
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

5.  Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach.

Authors:  Amanda R Pulsifer; Aruna Vashishta; Shane A Reeves; Jennifer K Wolfe; Samantha G Palace; Megan K Proulx; Jon Goguen; Sobha R Bodduluri; Bodduluri Haribabu; Silvia M Uriarte; Matthew B Lawrenz
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

6.  A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.

Authors:  Yue Zhang; Joseph T Barbieri
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 7.  Manipulation of Focal Adhesion Signaling by Pathogenic Microbes.

Authors:  Korinn N Murphy; Amanda J Brinkworth
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

8.  Context-dependent protein folding of a virulence peptide in the bacterial and host environments: structure of an SycH-YopH chaperone-effector complex.

Authors:  Milos Vujanac; C Erec Stebbins
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-03-09

Review 9.  Translocated effectors of Yersinia.

Authors:  Hiroyuki Matsumoto; Glenn M Young
Journal:  Curr Opin Microbiol       Date:  2009-02       Impact factor: 7.934

10.  YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia.

Authors:  Angelene M Cantwell; Sarah S Bubeck; Peter H Dube
Journal:  BMC Immunol       Date:  2010-06-16       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.